" /> Cerebrotendinous xanthomatosis - CISMeF





Preferred Label : Cerebrotendinous xanthomatosis;

Symbol : CTX;

CISMeF acronym : CTX;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Cerebral cholesterinosis;

Description : Cerebrotendinous xanthomatosis is a rare inherited lipid-storage disease characterized clinically by progressive neurologic dysfunction (cerebellar ataxia beginning after puberty, systemic spinal cord involvement and a pseudobulbar phase leading to death), premature atherosclerosis, and cataracts. Large deposits of cholesterol and cholestanol are found in virtually every tissue, particularly the Achilles tendons, brain, and lungs. Cholestanol, the 5-alpha-dihydro derivative of cholesterol, is enriched relative to cholesterol in all tissues. The diagnosis can be made by demonstrating cholestanol in abnormal amounts in the serum and tendon of persons suspected of being affected. Plasma cholesterol concentrations are low normal in CTX patients. Dotti et al. (2001) examined the ophthalmologic findings of 13 CTX patients. In addition to cataracts, which were found in all cases, optic disc pallor was identified in 6 of the patients. Premature retinal senescence was also observed. In a tabular presentation, Moghadasian et al. (2002) compared and contrasted CTX with 2 other lipid disorders with certain similarities and clinical course: familial hypercholesterolemia (143890) and sitosterolemia (210250).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutations in the cytochrome P450, subfamily XXVIIA, polypeptide 1 gene (CYP27A1, 213700.0001);

Laboratory abnormalities : Normal to slightly elevated plasma cholesterol; Elevated plasma cholestanol; Elevated urinary 7 alpha-hydroxylated bile alcohols; Sterol 27-hydroxylase deficiency;

Prefixed ID : #213700;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.